Dow Down 0.22% Nasdaq Up 0.14%

Epizyme, Inc. (EPZM)

-NasdaqGS
33.58 Up 1.03(3.16%) Aug 22, 4:00PM EDT
Prev Close:32.55
Open:32.67
Bid:25.00 x 200
Ask:38.00 x 200
1y Target Est:45.00
Beta:3.513
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:32.23 - 33.86
52wk Range:18.10 - 42.71
Volume:388,589
Avg Vol (3m):284,598
Market Cap:1.13B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EPZMUp 3.16%1.13B
GSKDown 0.04%114.53B
NVS 0.00%215.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.62
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback